Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Models, Genetic | 58 | 2022 | 3430 | 4.540 |
Why?
|
Genome-Wide Association Study | 79 | 2023 | 12676 | 3.350 |
Why?
|
Polymorphism, Single Nucleotide | 91 | 2023 | 15920 | 2.460 |
Why?
|
Genetic Predisposition to Disease | 85 | 2023 | 17897 | 2.260 |
Why?
|
Linkage Disequilibrium | 37 | 2019 | 1994 | 2.250 |
Why?
|
Family | 31 | 2020 | 3192 | 2.110 |
Why?
|
Genetic Association Studies | 15 | 2020 | 2731 | 1.920 |
Why?
|
Computer Simulation | 40 | 2023 | 6224 | 1.830 |
Why?
|
Antitubercular Agents | 13 | 2019 | 1374 | 1.630 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 34 | 2023 | 3201 | 1.600 |
Why?
|
Nuclear Family | 9 | 2017 | 311 | 1.570 |
Why?
|
Genetics, Population | 13 | 2017 | 935 | 1.530 |
Why?
|
Genetic Markers | 23 | 2016 | 2599 | 1.520 |
Why?
|
Asthma | 53 | 2023 | 6230 | 1.430 |
Why?
|
Genetic Linkage | 16 | 2019 | 2340 | 1.420 |
Why?
|
Genome, Human | 25 | 2019 | 4423 | 1.400 |
Why?
|
Genetic Pleiotropy | 2 | 2022 | 181 | 1.230 |
Why?
|
Quantitative Trait, Heritable | 14 | 2013 | 540 | 1.190 |
Why?
|
Quantitative Trait Loci | 14 | 2016 | 2113 | 1.180 |
Why?
|
Models, Statistical | 21 | 2018 | 5081 | 1.180 |
Why?
|
Software | 15 | 2019 | 4431 | 1.150 |
Why?
|
Phenotype | 49 | 2023 | 16575 | 1.130 |
Why?
|
Genome | 5 | 2024 | 1738 | 1.120 |
Why?
|
Mycobacterium tuberculosis | 16 | 2018 | 1912 | 1.090 |
Why?
|
Tuberculosis, Multidrug-Resistant | 7 | 2019 | 934 | 1.040 |
Why?
|
Mendelian Randomization Analysis | 2 | 2022 | 1010 | 1.030 |
Why?
|
Genetic Variation | 22 | 2022 | 6567 | 1.020 |
Why?
|
Molecular Epidemiology | 7 | 2021 | 470 | 1.000 |
Why?
|
Gene Frequency | 28 | 2023 | 3603 | 0.970 |
Why?
|
Cluster Analysis | 8 | 2022 | 2706 | 0.960 |
Why?
|
Tuberculosis, Pulmonary | 7 | 2018 | 830 | 0.940 |
Why?
|
Extensively Drug-Resistant Tuberculosis | 4 | 2018 | 85 | 0.900 |
Why?
|
Genetic Testing | 12 | 2013 | 3537 | 0.860 |
Why?
|
DNA Methylation | 4 | 2024 | 4384 | 0.860 |
Why?
|
Algorithms | 25 | 2024 | 14025 | 0.830 |
Why?
|
Genomics | 10 | 2024 | 5828 | 0.810 |
Why?
|
Haplotypes | 18 | 2017 | 2715 | 0.790 |
Why?
|
Genotype | 48 | 2015 | 12985 | 0.750 |
Why?
|
Genetic Loci | 11 | 2023 | 2623 | 0.730 |
Why?
|
Chromosome Mapping | 11 | 2014 | 4612 | 0.710 |
Why?
|
Multiple Organ Failure | 1 | 2023 | 386 | 0.710 |
Why?
|
Cleft Lip | 7 | 2014 | 506 | 0.710 |
Why?
|
Pedigree | 15 | 2019 | 4537 | 0.700 |
Why?
|
Latent Tuberculosis | 4 | 2015 | 224 | 0.670 |
Why?
|
Clofazimine | 2 | 2018 | 41 | 0.670 |
Why?
|
Alzheimer Disease | 20 | 2024 | 8603 | 0.670 |
Why?
|
Sequence Analysis, DNA | 9 | 2017 | 4739 | 0.660 |
Why?
|
Data Interpretation, Statistical | 9 | 2022 | 2691 | 0.640 |
Why?
|
Receptor, Angiotensin, Type 2 | 1 | 2018 | 60 | 0.630 |
Why?
|
Tuberculosis | 10 | 2016 | 2016 | 0.630 |
Why?
|
Oligonucleotide Array Sequence Analysis | 6 | 2024 | 3777 | 0.620 |
Why?
|
Genetic Techniques | 4 | 2011 | 428 | 0.600 |
Why?
|
Pulmonary Aspergillosis | 1 | 2018 | 47 | 0.590 |
Why?
|
Humans | 223 | 2024 | 761208 | 0.560 |
Why?
|
Genome, Viral | 1 | 2021 | 665 | 0.550 |
Why?
|
Cleft Palate | 5 | 2014 | 589 | 0.550 |
Why?
|
Databases, Genetic | 7 | 2021 | 1741 | 0.540 |
Why?
|
Gene Dosage | 3 | 2008 | 1217 | 0.500 |
Why?
|
Bronchi | 3 | 2018 | 843 | 0.500 |
Why?
|
Case-Control Studies | 40 | 2022 | 22174 | 0.490 |
Why?
|
Forced Expiratory Volume | 12 | 2022 | 1813 | 0.460 |
Why?
|
Thiophenes | 1 | 2018 | 569 | 0.450 |
Why?
|
Environment | 3 | 2010 | 1122 | 0.420 |
Why?
|
Multifactorial Inheritance | 4 | 2024 | 1387 | 0.420 |
Why?
|
Bronchoscopy | 2 | 2018 | 909 | 0.420 |
Why?
|
Principal Component Analysis | 7 | 2023 | 942 | 0.410 |
Why?
|
Pharmacogenetics | 5 | 2010 | 675 | 0.400 |
Why?
|
Genetic Diseases, Inborn | 3 | 2010 | 603 | 0.390 |
Why?
|
Data Compression | 1 | 2012 | 68 | 0.390 |
Why?
|
Smoking | 12 | 2022 | 9055 | 0.370 |
Why?
|
Alleles | 15 | 2020 | 6857 | 0.370 |
Why?
|
Immunoassay | 2 | 2014 | 743 | 0.360 |
Why?
|
Aorta | 1 | 2018 | 2040 | 0.360 |
Why?
|
Genes | 2 | 2013 | 1820 | 0.350 |
Why?
|
Biometry | 3 | 2010 | 563 | 0.350 |
Why?
|
Epigenesis, Genetic | 1 | 2023 | 3788 | 0.340 |
Why?
|
Receptors, Immunologic | 4 | 2022 | 1408 | 0.340 |
Why?
|
Attitude | 1 | 2014 | 771 | 0.330 |
Why?
|
DNA Copy Number Variations | 4 | 2013 | 2024 | 0.320 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2018 | 1228 | 0.310 |
Why?
|
Sulfonamides | 1 | 2018 | 1977 | 0.310 |
Why?
|
Rare Diseases | 1 | 2014 | 624 | 0.300 |
Why?
|
Bayes Theorem | 4 | 2022 | 2329 | 0.300 |
Why?
|
Meta-Analysis as Topic | 2 | 2015 | 1381 | 0.300 |
Why?
|
Interleukin-2 | 2 | 2014 | 1891 | 0.290 |
Why?
|
Viral Load | 2 | 2016 | 3328 | 0.280 |
Why?
|
Selection Bias | 2 | 2022 | 359 | 0.280 |
Why?
|
Statistics as Topic | 2 | 2010 | 2359 | 0.280 |
Why?
|
Body Mass Index | 9 | 2021 | 12952 | 0.260 |
Why?
|
Programming Languages | 1 | 2006 | 130 | 0.260 |
Why?
|
Linear Models | 6 | 2024 | 5869 | 0.260 |
Why?
|
Child | 49 | 2023 | 80152 | 0.260 |
Why?
|
Genetics, Medical | 1 | 2008 | 334 | 0.250 |
Why?
|
Male | 88 | 2024 | 360693 | 0.250 |
Why?
|
Research Design | 6 | 2011 | 6180 | 0.230 |
Why?
|
Germany | 4 | 2014 | 872 | 0.230 |
Why?
|
Models, Theoretical | 3 | 2012 | 3571 | 0.230 |
Why?
|
Apolipoproteins E | 4 | 2017 | 1443 | 0.220 |
Why?
|
HIV Core Protein p24 | 1 | 2004 | 244 | 0.220 |
Why?
|
DNA Probes | 1 | 2024 | 542 | 0.220 |
Why?
|
Serpin E2 | 4 | 2011 | 48 | 0.220 |
Why?
|
Female | 87 | 2024 | 392544 | 0.220 |
Why?
|
Schizophrenia | 5 | 2015 | 6930 | 0.220 |
Why?
|
Probability | 5 | 2019 | 2478 | 0.220 |
Why?
|
Hypersensitivity, Immediate | 2 | 2023 | 348 | 0.220 |
Why?
|
Phylogeny | 2 | 2021 | 2809 | 0.220 |
Why?
|
Europe | 7 | 2021 | 3423 | 0.210 |
Why?
|
Tuberculin | 2 | 2014 | 64 | 0.210 |
Why?
|
Polymorphism, Genetic | 10 | 2009 | 4243 | 0.210 |
Why?
|
Chromosomes, Human, Pair 15 | 5 | 2015 | 361 | 0.200 |
Why?
|
Dystrophin-Associated Proteins | 1 | 2022 | 59 | 0.200 |
Why?
|
Bronchodilator Agents | 5 | 2015 | 512 | 0.190 |
Why?
|
Gene Regulatory Networks | 1 | 2010 | 1743 | 0.190 |
Why?
|
CpG Islands | 2 | 2024 | 1190 | 0.190 |
Why?
|
Inheritance Patterns | 3 | 2013 | 341 | 0.180 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2015 | 3634 | 0.180 |
Why?
|
Bronchoalveolar Lavage Fluid | 4 | 2011 | 753 | 0.180 |
Why?
|
Cell Adhesion Molecules | 2 | 2019 | 1603 | 0.180 |
Why?
|
Emphysema | 1 | 2023 | 238 | 0.170 |
Why?
|
Gene Expression | 4 | 2023 | 7571 | 0.170 |
Why?
|
User-Computer Interface | 1 | 2006 | 1393 | 0.170 |
Why?
|
Pliability | 1 | 2019 | 59 | 0.170 |
Why?
|
HIV Infections | 9 | 2016 | 17347 | 0.170 |
Why?
|
Nerve Tissue Proteins | 3 | 2012 | 4404 | 0.170 |
Why?
|
Computing Methodologies | 2 | 2011 | 16 | 0.170 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2019 | 117 | 0.170 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2020 | 2871 | 0.170 |
Why?
|
T-Lymphocytes | 2 | 2014 | 10203 | 0.160 |
Why?
|
alpha-Macroglobulins | 2 | 2010 | 60 | 0.160 |
Why?
|
Middle Aged | 48 | 2022 | 220853 | 0.160 |
Why?
|
Tuberculin Test | 3 | 2015 | 205 | 0.160 |
Why?
|
Suicide | 1 | 2010 | 1602 | 0.160 |
Why?
|
Paracoccidioidomycosis | 1 | 2018 | 10 | 0.160 |
Why?
|
Amyloid beta-Protein Precursor | 3 | 2012 | 1111 | 0.160 |
Why?
|
North America | 2 | 2021 | 1284 | 0.150 |
Why?
|
Coccidioidomycosis | 1 | 2018 | 37 | 0.150 |
Why?
|
Lung Diseases | 2 | 2019 | 1910 | 0.150 |
Why?
|
Pancreatic Elastase | 1 | 2018 | 126 | 0.150 |
Why?
|
Histoplasmosis | 1 | 2018 | 63 | 0.150 |
Why?
|
Aspergillus | 1 | 2018 | 94 | 0.150 |
Why?
|
Interferon Regulatory Factors | 1 | 2019 | 261 | 0.150 |
Why?
|
Lung | 8 | 2018 | 9979 | 0.150 |
Why?
|
Age of Onset | 7 | 2017 | 3307 | 0.150 |
Why?
|
Epigenomics | 1 | 2023 | 944 | 0.150 |
Why?
|
HIV-1 | 4 | 2013 | 6851 | 0.140 |
Why?
|
Pulmonary Emphysema | 1 | 2023 | 683 | 0.140 |
Why?
|
Child Development Disorders, Pervasive | 2 | 2013 | 600 | 0.140 |
Why?
|
Adult | 45 | 2019 | 221119 | 0.140 |
Why?
|
Brazil | 1 | 2021 | 1228 | 0.140 |
Why?
|
Statistics, Nonparametric | 1 | 2003 | 2854 | 0.140 |
Why?
|
Interferon-gamma | 4 | 2014 | 3155 | 0.140 |
Why?
|
Vital Capacity | 1 | 2019 | 970 | 0.140 |
Why?
|
Biostatistics | 1 | 2018 | 164 | 0.130 |
Why?
|
Physicians | 1 | 2014 | 4584 | 0.130 |
Why?
|
Multigene Family | 2 | 2013 | 1075 | 0.130 |
Why?
|
rac GTP-Binding Proteins | 1 | 2017 | 162 | 0.130 |
Why?
|
Neuropeptides | 1 | 2022 | 944 | 0.130 |
Why?
|
Chromosomes, Human, Pair 14 | 2 | 2014 | 286 | 0.130 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 5 | 2008 | 3707 | 0.130 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2018 | 630 | 0.130 |
Why?
|
Cohort Studies | 20 | 2018 | 41496 | 0.130 |
Why?
|
Regression Analysis | 4 | 2018 | 6345 | 0.130 |
Why?
|
Pulmonary Medicine | 1 | 2018 | 221 | 0.130 |
Why?
|
Risk | 4 | 2020 | 9616 | 0.130 |
Why?
|
Carrier Proteins | 4 | 2014 | 4935 | 0.130 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2016 | 112 | 0.130 |
Why?
|
Receptors, Cell Surface | 4 | 2006 | 2802 | 0.120 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2004 | 1895 | 0.120 |
Why?
|
International Cooperation | 2 | 2019 | 1423 | 0.120 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2018 | 631 | 0.120 |
Why?
|
Membrane Glycoproteins | 5 | 2014 | 3696 | 0.120 |
Why?
|
Treatment Failure | 2 | 2018 | 2643 | 0.120 |
Why?
|
Population | 1 | 2015 | 141 | 0.120 |
Why?
|
Receptors, Chemokine | 2 | 2012 | 654 | 0.120 |
Why?
|
Phospholipase D | 1 | 2015 | 67 | 0.120 |
Why?
|
Fluoroimmunoassay | 1 | 2014 | 30 | 0.120 |
Why?
|
Causality | 1 | 2021 | 1244 | 0.120 |
Why?
|
China | 1 | 2021 | 2374 | 0.120 |
Why?
|
Rats, Wistar | 1 | 2018 | 1848 | 0.120 |
Why?
|
Multivariate Analysis | 3 | 2016 | 12052 | 0.120 |
Why?
|
Communicable Diseases | 1 | 2022 | 873 | 0.110 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2014 | 124 | 0.110 |
Why?
|
Confidence Intervals | 1 | 2019 | 2928 | 0.110 |
Why?
|
Anti-Asthmatic Agents | 3 | 2009 | 573 | 0.110 |
Why?
|
Tuberculosis Vaccines | 1 | 2014 | 48 | 0.110 |
Why?
|
Iron Regulatory Protein 2 | 2 | 2013 | 42 | 0.110 |
Why?
|
ADP-Ribosylation Factors | 1 | 2014 | 133 | 0.110 |
Why?
|
Disease-Free Survival | 1 | 2024 | 6819 | 0.110 |
Why?
|
Pectoralis Muscles | 1 | 2014 | 84 | 0.110 |
Why?
|
Genetic Heterogeneity | 2 | 2015 | 734 | 0.110 |
Why?
|
Aged | 34 | 2022 | 169288 | 0.110 |
Why?
|
T-Lymphocyte Subsets | 2 | 2016 | 1803 | 0.110 |
Why?
|
Chemokine CXCL10 | 1 | 2014 | 309 | 0.110 |
Why?
|
Family Health | 3 | 2014 | 1254 | 0.110 |
Why?
|
Air Pollution, Indoor | 1 | 2020 | 900 | 0.110 |
Why?
|
Rhinitis, Allergic, Perennial | 1 | 2013 | 59 | 0.100 |
Why?
|
Interleukin-13 | 2 | 2007 | 392 | 0.100 |
Why?
|
Contact Tracing | 1 | 2015 | 272 | 0.100 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2015 | 316 | 0.100 |
Why?
|
Calcium Channels, L-Type | 1 | 2014 | 241 | 0.100 |
Why?
|
RNA, Viral | 2 | 2016 | 2839 | 0.100 |
Why?
|
Base Sequence | 2 | 2022 | 12404 | 0.100 |
Why?
|
Chromosomes, Human, Pair 19 | 2 | 2011 | 350 | 0.100 |
Why?
|
Reproducibility of Results | 4 | 2024 | 20119 | 0.100 |
Why?
|
Parents | 3 | 2019 | 3564 | 0.100 |
Why?
|
HLA-DQ Antigens | 1 | 2012 | 190 | 0.100 |
Why?
|
Travel | 1 | 2018 | 796 | 0.100 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 1 | 2013 | 110 | 0.100 |
Why?
|
Homeodomain Proteins | 2 | 2012 | 2414 | 0.100 |
Why?
|
Young Adult | 18 | 2019 | 59221 | 0.100 |
Why?
|
Transcription Factors | 4 | 2015 | 12099 | 0.100 |
Why?
|
Blood Group Antigens | 1 | 2013 | 184 | 0.100 |
Why?
|
Aged, 80 and over | 15 | 2022 | 58952 | 0.100 |
Why?
|
Transients and Migrants | 1 | 2014 | 165 | 0.100 |
Why?
|
Adolescent | 20 | 2022 | 88298 | 0.100 |
Why?
|
World Health Organization | 1 | 2018 | 1321 | 0.100 |
Why?
|
Chondroitin Sulfate Proteoglycans | 1 | 2012 | 141 | 0.100 |
Why?
|
Atrial Natriuretic Factor | 2 | 2010 | 350 | 0.100 |
Why?
|
Sample Size | 3 | 2009 | 843 | 0.100 |
Why?
|
Likelihood Functions | 2 | 2012 | 991 | 0.100 |
Why?
|
Chromosomes, Human | 1 | 2013 | 442 | 0.100 |
Why?
|
Radiography, Thoracic | 1 | 2018 | 1302 | 0.100 |
Why?
|
Epistasis, Genetic | 1 | 2013 | 350 | 0.100 |
Why?
|
Introns | 3 | 2009 | 968 | 0.090 |
Why?
|
beta-Defensins | 1 | 2011 | 59 | 0.090 |
Why?
|
Obesity | 3 | 2009 | 12939 | 0.090 |
Why?
|
Toll-Like Receptor 1 | 1 | 2011 | 48 | 0.090 |
Why?
|
Influenza, Human | 1 | 2022 | 1521 | 0.090 |
Why?
|
Interleukin-10 | 3 | 2009 | 1176 | 0.090 |
Why?
|
Skin Tests | 2 | 2010 | 638 | 0.090 |
Why?
|
Receptors, G-Protein-Coupled | 3 | 2010 | 1249 | 0.090 |
Why?
|
Drug Therapy, Combination | 2 | 2018 | 6304 | 0.090 |
Why?
|
Survival Analysis | 1 | 2004 | 10088 | 0.090 |
Why?
|
Virus Replication | 2 | 2012 | 2426 | 0.090 |
Why?
|
Recombination, Genetic | 1 | 2015 | 1518 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 5 | 2012 | 4574 | 0.090 |
Why?
|
Receptors, Corticotropin-Releasing Hormone | 2 | 2008 | 88 | 0.090 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2014 | 4340 | 0.090 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2012 | 343 | 0.090 |
Why?
|
S100 Proteins | 1 | 2011 | 216 | 0.090 |
Why?
|
Chromosomes, Human, Pair 10 | 2 | 2012 | 277 | 0.090 |
Why?
|
Immunoglobulin E | 3 | 2023 | 1505 | 0.090 |
Why?
|
Matrix Metalloproteinase 12 | 1 | 2009 | 44 | 0.090 |
Why?
|
Candida albicans | 1 | 2013 | 372 | 0.090 |
Why?
|
Glutamate Decarboxylase | 1 | 2010 | 239 | 0.080 |
Why?
|
NF-kappa B | 1 | 2018 | 2475 | 0.080 |
Why?
|
Seafood | 1 | 2013 | 393 | 0.080 |
Why?
|
Fishes | 1 | 2013 | 600 | 0.080 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2011 | 175 | 0.080 |
Why?
|
Receptors, Glucocorticoid | 1 | 2011 | 303 | 0.080 |
Why?
|
Adrenergic beta-Agonists | 2 | 2008 | 346 | 0.080 |
Why?
|
Genes, Homeobox | 1 | 2010 | 285 | 0.080 |
Why?
|
Proportional Hazards Models | 1 | 2024 | 12474 | 0.080 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2009 | 41 | 0.080 |
Why?
|
Immunocompromised Host | 1 | 2014 | 858 | 0.080 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2013 | 4372 | 0.080 |
Why?
|
Severity of Illness Index | 7 | 2018 | 15841 | 0.080 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2017 | 955 | 0.080 |
Why?
|
Interleukin-1 Receptor-Associated Kinases | 1 | 2009 | 76 | 0.080 |
Why?
|
Lectins, C-Type | 1 | 2012 | 585 | 0.080 |
Why?
|
Heart Diseases | 3 | 2010 | 2795 | 0.080 |
Why?
|
Lipopolysaccharides | 1 | 2016 | 2199 | 0.080 |
Why?
|
Integrin beta3 | 1 | 2009 | 120 | 0.080 |
Why?
|
Antigens, Bacterial | 3 | 2014 | 1140 | 0.080 |
Why?
|
Mutation | 4 | 2021 | 30002 | 0.080 |
Why?
|
Costa Rica | 3 | 2019 | 180 | 0.080 |
Why?
|
Longitudinal Studies | 8 | 2019 | 14610 | 0.080 |
Why?
|
Chemokines | 1 | 2012 | 956 | 0.080 |
Why?
|
Membrane Proteins | 4 | 2009 | 7851 | 0.080 |
Why?
|
Health Resources | 1 | 2014 | 934 | 0.080 |
Why?
|
Spirometry | 3 | 2022 | 928 | 0.080 |
Why?
|
Ventricular Dysfunction | 1 | 2009 | 144 | 0.080 |
Why?
|
Child, Preschool | 11 | 2019 | 42224 | 0.080 |
Why?
|
Arginase | 1 | 2008 | 79 | 0.080 |
Why?
|
Spouses | 1 | 2010 | 284 | 0.070 |
Why?
|
Immunologic Tests | 1 | 2008 | 104 | 0.070 |
Why?
|
DEAD-box RNA Helicases | 1 | 2011 | 380 | 0.070 |
Why?
|
Population Groups | 1 | 2009 | 207 | 0.070 |
Why?
|
Indians, Central American | 1 | 2007 | 19 | 0.070 |
Why?
|
Receptors, Dopamine D5 | 1 | 2007 | 32 | 0.070 |
Why?
|
Data Collection | 2 | 2014 | 3320 | 0.070 |
Why?
|
HIV Seropositivity | 1 | 2013 | 957 | 0.070 |
Why?
|
Leukocytes, Mononuclear | 1 | 2014 | 1838 | 0.070 |
Why?
|
Receptors, Dopamine D4 | 1 | 2008 | 169 | 0.070 |
Why?
|
Apolipoprotein E2 | 1 | 2007 | 135 | 0.070 |
Why?
|
Databases, Factual | 1 | 2022 | 7966 | 0.070 |
Why?
|
Bronchial Hyperreactivity | 2 | 2005 | 301 | 0.070 |
Why?
|
Antigens, Surface | 1 | 2011 | 1607 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2014 | 1651 | 0.070 |
Why?
|
False Positive Reactions | 1 | 2009 | 958 | 0.070 |
Why?
|
Drug Costs | 1 | 2014 | 1183 | 0.070 |
Why?
|
Logistic Models | 5 | 2016 | 13249 | 0.070 |
Why?
|
Risk Factors | 10 | 2022 | 74239 | 0.070 |
Why?
|
Anti-Retroviral Agents | 1 | 2016 | 1784 | 0.070 |
Why?
|
RNA, Messenger | 4 | 2014 | 12747 | 0.070 |
Why?
|
Chromosomes, Human, Pair 4 | 3 | 2015 | 375 | 0.060 |
Why?
|
Frizzled Receptors | 1 | 2006 | 91 | 0.060 |
Why?
|
Recombinant Fusion Proteins | 1 | 2014 | 3726 | 0.060 |
Why?
|
Interleukin-1 | 1 | 2009 | 1250 | 0.060 |
Why?
|
Lymphotoxin-alpha | 1 | 2005 | 93 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 3803 | 0.060 |
Why?
|
Prospective Studies | 6 | 2022 | 54435 | 0.060 |
Why?
|
Social Environment | 1 | 2010 | 1022 | 0.060 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2014 | 1492 | 0.060 |
Why?
|
Maximal Midexpiratory Flow Rate | 1 | 2004 | 75 | 0.060 |
Why?
|
Promoter Regions, Genetic | 4 | 2009 | 5773 | 0.060 |
Why?
|
Serpins | 1 | 2006 | 247 | 0.060 |
Why?
|
Computer Graphics | 1 | 2006 | 338 | 0.060 |
Why?
|
Treatment Outcome | 8 | 2018 | 64681 | 0.060 |
Why?
|
Glucocorticoids | 2 | 2011 | 2159 | 0.060 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2005 | 368 | 0.060 |
Why?
|
Incidence | 4 | 2018 | 21365 | 0.060 |
Why?
|
Disease Progression | 2 | 2018 | 13511 | 0.060 |
Why?
|
Computational Biology | 2 | 2014 | 3499 | 0.060 |
Why?
|
Cooperative Behavior | 2 | 2014 | 1506 | 0.060 |
Why?
|
Penetrance | 2 | 2017 | 382 | 0.060 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2005 | 452 | 0.060 |
Why?
|
Exons | 1 | 2009 | 2380 | 0.050 |
Why?
|
Apolipoprotein E4 | 1 | 2007 | 709 | 0.050 |
Why?
|
Repressor Proteins | 1 | 2014 | 2974 | 0.050 |
Why?
|
Disease | 1 | 2008 | 670 | 0.050 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2004 | 386 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2013 | 2640 | 0.050 |
Why?
|
Oxygen | 1 | 2014 | 4227 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12976 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2018 | 20588 | 0.050 |
Why?
|
Blood Pressure | 1 | 2018 | 8479 | 0.050 |
Why?
|
Staphylococcus aureus | 1 | 2011 | 1450 | 0.050 |
Why?
|
Bipolar Disorder | 3 | 2012 | 5092 | 0.050 |
Why?
|
Eosinophilia | 1 | 2007 | 557 | 0.050 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2003 | 217 | 0.050 |
Why?
|
Dithionitrobenzoic Acid | 1 | 2022 | 20 | 0.050 |
Why?
|
Metalloendopeptidases | 1 | 2004 | 389 | 0.050 |
Why?
|
Fathers | 1 | 2005 | 375 | 0.050 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2004 | 1351 | 0.050 |
Why?
|
Prognosis | 2 | 2021 | 29687 | 0.050 |
Why?
|
Age Factors | 2 | 2010 | 18384 | 0.050 |
Why?
|
Follow-Up Studies | 5 | 2016 | 39126 | 0.050 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2003 | 430 | 0.050 |
Why?
|
Immunophenotyping | 2 | 2004 | 1867 | 0.050 |
Why?
|
Wnt Proteins | 1 | 2006 | 720 | 0.050 |
Why?
|
Receptors, Calcitriol | 1 | 2004 | 360 | 0.050 |
Why?
|
Dendritic Cells | 1 | 2013 | 2726 | 0.050 |
Why?
|
Staphylococcal Infections | 1 | 2011 | 1401 | 0.050 |
Why?
|
Interleukin-12 | 1 | 2004 | 578 | 0.050 |
Why?
|
Cytokines | 2 | 2014 | 7386 | 0.050 |
Why?
|
Immunosuppressive Agents | 1 | 2014 | 4190 | 0.050 |
Why?
|
Respiration | 1 | 2008 | 1656 | 0.050 |
Why?
|
Multicenter Studies as Topic | 3 | 2015 | 1702 | 0.050 |
Why?
|
Homozygote | 3 | 2011 | 1775 | 0.050 |
Why?
|
Eosinophils | 2 | 2023 | 951 | 0.050 |
Why?
|
Respiratory Function Tests | 3 | 2014 | 1685 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8663 | 0.040 |
Why?
|
Crosses, Genetic | 1 | 2001 | 752 | 0.040 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2009 | 1725 | 0.040 |
Why?
|
Cytomegalovirus | 2 | 2002 | 750 | 0.040 |
Why?
|
Metalloproteases | 1 | 2020 | 61 | 0.040 |
Why?
|
Coronary Artery Bypass | 1 | 2009 | 2193 | 0.040 |
Why?
|
Cystic Fibrosis | 1 | 2009 | 1283 | 0.040 |
Why?
|
Chi-Square Distribution | 2 | 2002 | 3418 | 0.040 |
Why?
|
Skin | 1 | 2013 | 4473 | 0.040 |
Why?
|
X Chromosome | 1 | 2023 | 816 | 0.040 |
Why?
|
Herpesvirus 4, Human | 2 | 2002 | 1076 | 0.040 |
Why?
|
Capreomycin | 1 | 2018 | 14 | 0.040 |
Why?
|
Interferons | 1 | 2022 | 702 | 0.040 |
Why?
|
Internet | 1 | 2011 | 3096 | 0.040 |
Why?
|
Amikacin | 1 | 2018 | 47 | 0.040 |
Why?
|
Kanamycin | 1 | 2018 | 63 | 0.040 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2019 | 189 | 0.040 |
Why?
|
Anti-HIV Agents | 1 | 2014 | 4526 | 0.040 |
Why?
|
Chromosomes, Human, Pair 9 | 2 | 2014 | 534 | 0.040 |
Why?
|
Biomedical Research | 1 | 2014 | 3434 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 12159 | 0.040 |
Why?
|
Analysis of Variance | 2 | 2003 | 6223 | 0.040 |
Why?
|
DNA Mutational Analysis | 2 | 2018 | 4107 | 0.040 |
Why?
|
Memory | 1 | 2007 | 2190 | 0.040 |
Why?
|
Fungi | 1 | 2020 | 337 | 0.040 |
Why?
|
Zinc Fingers | 1 | 2020 | 575 | 0.040 |
Why?
|
Time Factors | 2 | 2017 | 39957 | 0.040 |
Why?
|
Carbapenems | 1 | 2018 | 123 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2010 | 10218 | 0.040 |
Why?
|
DNA | 2 | 2009 | 7189 | 0.040 |
Why?
|
Cross-Sectional Studies | 4 | 2014 | 26071 | 0.030 |
Why?
|
Fibroblast Growth Factors | 1 | 2023 | 863 | 0.030 |
Why?
|
Protease Nexins | 2 | 2006 | 39 | 0.030 |
Why?
|
Cell Division | 1 | 2004 | 4451 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2004 | 1963 | 0.030 |
Why?
|
Fluoroquinolones | 1 | 2018 | 307 | 0.030 |
Why?
|
Lymphocyte Activation | 2 | 2004 | 5478 | 0.030 |
Why?
|
Cell Line | 1 | 2010 | 15545 | 0.030 |
Why?
|
Meat | 1 | 2019 | 584 | 0.030 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2011 | 3417 | 0.030 |
Why?
|
Austria | 1 | 2016 | 206 | 0.030 |
Why?
|
Proteins | 1 | 2010 | 5993 | 0.030 |
Why?
|
Cognition | 1 | 2013 | 6988 | 0.030 |
Why?
|
Clinical Trials as Topic | 4 | 2013 | 8003 | 0.030 |
Why?
|
Cachexia | 1 | 2017 | 202 | 0.030 |
Why?
|
Mycoses | 1 | 2018 | 386 | 0.030 |
Why?
|
Alcoholism | 1 | 2005 | 1973 | 0.030 |
Why?
|
Diet | 1 | 2013 | 8048 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2014 | 6919 | 0.030 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2014 | 21 | 0.030 |
Why?
|
Untranslated Regions | 1 | 2014 | 29 | 0.030 |
Why?
|
ADAM Proteins | 2 | 2007 | 238 | 0.030 |
Why?
|
Gene Expression Profiling | 4 | 2014 | 9416 | 0.030 |
Why?
|
Odds Ratio | 3 | 2013 | 9652 | 0.030 |
Why?
|
Depressive Disorder, Major | 1 | 2012 | 4767 | 0.030 |
Why?
|
Mutation, Missense | 2 | 2014 | 2567 | 0.030 |
Why?
|
Animals | 6 | 2018 | 168079 | 0.030 |
Why?
|
European Union | 1 | 2014 | 157 | 0.030 |
Why?
|
Antigens, CD | 1 | 2004 | 4009 | 0.030 |
Why?
|
Bone Morphogenetic Protein 4 | 1 | 2014 | 163 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 1 | 2006 | 4513 | 0.030 |
Why?
|
Boston | 2 | 2017 | 9327 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2005 | 3446 | 0.030 |
Why?
|
Pore Forming Cytotoxic Proteins | 2 | 2004 | 130 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2002 | 2307 | 0.030 |
Why?
|
Risk Assessment | 4 | 2019 | 24021 | 0.030 |
Why?
|
Injections, Intradermal | 1 | 2013 | 116 | 0.030 |
Why?
|
Reference Standards | 1 | 2017 | 1005 | 0.030 |
Why?
|
Perforin | 2 | 2004 | 166 | 0.030 |
Why?
|
Hypersensitivity | 1 | 2002 | 1167 | 0.030 |
Why?
|
Drosophila Proteins | 1 | 2002 | 1696 | 0.030 |
Why?
|
Chemokine CCL4 | 1 | 2012 | 126 | 0.030 |
Why?
|
Body Composition | 2 | 2014 | 2427 | 0.030 |
Why?
|
Dyspnea | 1 | 2021 | 1347 | 0.030 |
Why?
|
Chemoprevention | 1 | 2015 | 325 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2016 | 5871 | 0.030 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2014 | 418 | 0.030 |
Why?
|
Neurocan | 1 | 2012 | 21 | 0.030 |
Why?
|
Bronchoalveolar Lavage | 1 | 2012 | 129 | 0.030 |
Why?
|
Age Distribution | 1 | 2018 | 2871 | 0.030 |
Why?
|
Brain | 2 | 2012 | 27092 | 0.030 |
Why?
|
Immunity, Innate | 3 | 2011 | 3044 | 0.020 |
Why?
|
Chemokine CCL5 | 1 | 2012 | 214 | 0.020 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2016 | 585 | 0.020 |
Why?
|
Chronic Disease | 2 | 2004 | 9319 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2022 | 2803 | 0.020 |
Why?
|
ROC Curve | 2 | 2010 | 3584 | 0.020 |
Why?
|
Vaccination | 1 | 2004 | 3369 | 0.020 |
Why?
|
Sensitivity and Specificity | 3 | 2014 | 14675 | 0.020 |
Why?
|
Oximetry | 1 | 2014 | 459 | 0.020 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2012 | 310 | 0.020 |
Why?
|
Macrophages | 1 | 2006 | 5753 | 0.020 |
Why?
|
Infant | 2 | 2015 | 36169 | 0.020 |
Why?
|
Gene Duplication | 1 | 2012 | 314 | 0.020 |
Why?
|
Histone Deacetylase 1 | 1 | 2011 | 133 | 0.020 |
Why?
|
Open Reading Frames | 1 | 2014 | 811 | 0.020 |
Why?
|
Denmark | 1 | 2013 | 770 | 0.020 |
Why?
|
Receptors, CCR5 | 1 | 2012 | 487 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2007 | 9566 | 0.020 |
Why?
|
Ghana | 1 | 2011 | 315 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2016 | 1936 | 0.020 |
Why?
|
Africa South of the Sahara | 1 | 2012 | 745 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 2010 | 11476 | 0.020 |
Why?
|
Genetic Complementation Test | 1 | 2010 | 556 | 0.020 |
Why?
|
GTPase-Activating Proteins | 1 | 2013 | 470 | 0.020 |
Why?
|
Calcium Signaling | 1 | 2014 | 731 | 0.020 |
Why?
|
Rest | 1 | 2014 | 920 | 0.020 |
Why?
|
Receptors, Nicotinic | 1 | 2013 | 494 | 0.020 |
Why?
|
Receptors, Atrial Natriuretic Factor | 1 | 2009 | 43 | 0.020 |
Why?
|
Norway | 1 | 2010 | 499 | 0.020 |
Why?
|
Biopsy | 2 | 2011 | 6781 | 0.020 |
Why?
|
Respiratory Sounds | 1 | 2013 | 702 | 0.020 |
Why?
|
Ecology | 1 | 2009 | 104 | 0.020 |
Why?
|
Gene Expression Regulation | 3 | 2014 | 11856 | 0.020 |
Why?
|
Membrane Transport Proteins | 1 | 2014 | 1031 | 0.020 |
Why?
|
Epithelial Cells | 2 | 2011 | 3671 | 0.020 |
Why?
|
Demography | 1 | 2013 | 1641 | 0.020 |
Why?
|
Consensus | 1 | 2018 | 3134 | 0.020 |
Why?
|
Theophylline | 1 | 2008 | 131 | 0.020 |
Why?
|
Auditory Perceptual Disorders | 1 | 2008 | 36 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2014 | 1360 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2018 | 1427 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2012 | 1695 | 0.020 |
Why?
|
Neuropsychological Tests | 2 | 2013 | 7046 | 0.020 |
Why?
|
South Africa | 1 | 2013 | 1843 | 0.020 |
Why?
|
Gene Order | 1 | 2007 | 168 | 0.020 |
Why?
|
Metagenomics | 1 | 2011 | 463 | 0.020 |
Why?
|
Albuterol | 1 | 2008 | 211 | 0.020 |
Why?
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2007 | 88 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 2012 | 1386 | 0.020 |
Why?
|
Lysine | 1 | 2011 | 982 | 0.020 |
Why?
|
Potassium Channels, Inwardly Rectifying | 1 | 2007 | 144 | 0.020 |
Why?
|
Immunologic Memory | 1 | 2013 | 1361 | 0.020 |
Why?
|
Inflammation | 1 | 2006 | 10759 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2013 | 11067 | 0.020 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2009 | 450 | 0.020 |
Why?
|
Stem Cell Transplantation | 1 | 2014 | 1600 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10553 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2009 | 748 | 0.020 |
Why?
|
Syndrome | 1 | 2012 | 3271 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8457 | 0.020 |
Why?
|
Administration, Inhalation | 1 | 2009 | 1159 | 0.020 |
Why?
|
Societies, Medical | 1 | 2018 | 3923 | 0.020 |
Why?
|
Ligands | 1 | 2012 | 3264 | 0.020 |
Why?
|
Arachidonate 5-Lipoxygenase | 1 | 2006 | 128 | 0.020 |
Why?
|
Area Under Curve | 1 | 2010 | 1636 | 0.020 |
Why?
|
Leukotriene Antagonists | 1 | 2006 | 124 | 0.020 |
Why?
|
Environmental Exposure | 1 | 2020 | 4479 | 0.020 |
Why?
|
Siblings | 1 | 2009 | 824 | 0.020 |
Why?
|
Receptors, Adrenergic, beta | 1 | 2006 | 242 | 0.020 |
Why?
|
Pulmonary Surfactant-Associated Protein B | 1 | 2005 | 43 | 0.020 |
Why?
|
Lod Score | 1 | 2005 | 600 | 0.020 |
Why?
|
Toll-Like Receptor 10 | 1 | 2004 | 12 | 0.010 |
Why?
|
Surgical Procedures, Operative | 1 | 2016 | 1923 | 0.010 |
Why?
|
Epoxy Compounds | 1 | 2005 | 137 | 0.010 |
Why?
|
Interleukin-12 Subunit p40 | 1 | 2004 | 57 | 0.010 |
Why?
|
Heme Oxygenase (Decyclizing) | 1 | 2005 | 167 | 0.010 |
Why?
|
Troponin I | 1 | 2009 | 652 | 0.010 |
Why?
|
Quebec | 1 | 2004 | 139 | 0.010 |
Why?
|
Epoxide Hydrolases | 1 | 2005 | 122 | 0.010 |
Why?
|
Organ Transplantation | 1 | 2014 | 1165 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8519 | 0.010 |
Why?
|
Cadherins | 1 | 2008 | 902 | 0.010 |
Why?
|
Mixed Function Oxygenases | 1 | 2005 | 265 | 0.010 |
Why?
|
Serine Endopeptidases | 1 | 2009 | 1022 | 0.010 |
Why?
|
Heterozygote | 1 | 2010 | 2778 | 0.010 |
Why?
|
Placebos | 1 | 2008 | 1666 | 0.010 |
Why?
|
Task Performance and Analysis | 1 | 2007 | 763 | 0.010 |
Why?
|
United States | 3 | 2013 | 72339 | 0.010 |
Why?
|
Genes, Recessive | 1 | 2006 | 622 | 0.010 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2005 | 781 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2014 | 3596 | 0.010 |
Why?
|
Antigen-Presenting Cells | 1 | 2006 | 965 | 0.010 |
Why?
|
Chromatin | 1 | 2014 | 2946 | 0.010 |
Why?
|
Mothers | 1 | 2013 | 2193 | 0.010 |
Why?
|
Respiratory Hypersensitivity | 1 | 2004 | 271 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 2014 | 2478 | 0.010 |
Why?
|
Double-Blind Method | 2 | 2008 | 12341 | 0.010 |
Why?
|
HLA Antigens | 1 | 2007 | 1331 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2007 | 4167 | 0.010 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2005 | 563 | 0.010 |
Why?
|
3' Untranslated Regions | 1 | 2004 | 514 | 0.010 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2004 | 638 | 0.010 |
Why?
|
Self Report | 1 | 2013 | 3727 | 0.010 |
Why?
|
Health Care Costs | 1 | 2014 | 3239 | 0.010 |
Why?
|
Medical History Taking | 1 | 2005 | 773 | 0.010 |
Why?
|
Receptors, CCR7 | 1 | 2001 | 106 | 0.010 |
Why?
|
Microsatellite Repeats | 1 | 2003 | 782 | 0.010 |
Why?
|
L-Selectin | 1 | 2001 | 212 | 0.010 |
Why?
|
Histones | 1 | 2011 | 2570 | 0.010 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2007 | 1348 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2012 | 13402 | 0.010 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2004 | 822 | 0.010 |
Why?
|
Lymphocyte Subsets | 1 | 2001 | 312 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 17598 | 0.010 |
Why?
|
Body Weight | 1 | 2010 | 4618 | 0.010 |
Why?
|
Lymphatic Diseases | 1 | 2001 | 320 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 2009 | 1812 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 2014 | 3753 | 0.010 |
Why?
|
Toll-Like Receptors | 1 | 2002 | 575 | 0.010 |
Why?
|
Toll-Like Receptor 4 | 1 | 2002 | 577 | 0.010 |
Why?
|
Retrospective Studies | 3 | 2016 | 80674 | 0.010 |
Why?
|
Mental Disorders | 1 | 2018 | 6823 | 0.010 |
Why?
|
Massachusetts | 1 | 2010 | 8837 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15308 | 0.010 |
Why?
|
Signal Transduction | 2 | 2014 | 23416 | 0.010 |
Why?
|
Reference Values | 1 | 2004 | 4921 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2014 | 5425 | 0.010 |
Why?
|
Up-Regulation | 1 | 2006 | 4111 | 0.010 |
Why?
|
Monocytes | 1 | 2006 | 2570 | 0.010 |
Why?
|
Virus Diseases | 1 | 2002 | 716 | 0.010 |
Why?
|
HIV | 1 | 2002 | 1581 | 0.010 |
Why?
|
Allergens | 1 | 2002 | 1433 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2015 | 26199 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2005 | 2897 | 0.010 |
Why?
|
Cognition Disorders | 1 | 2007 | 3976 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2002 | 6067 | 0.010 |
Why?
|
Hospitalization | 1 | 2013 | 10707 | 0.010 |
Why?
|
Insulin | 1 | 2007 | 6588 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2005 | 7571 | 0.010 |
Why?
|
Pregnancy | 1 | 2013 | 29893 | 0.010 |
Why?
|
Mice | 2 | 2006 | 81326 | 0.000 |
Why?
|
Practice Guidelines as Topic | 1 | 2006 | 7400 | 0.000 |
Why?
|
Apoptosis | 1 | 2004 | 9477 | 0.000 |
Why?
|
Cell Differentiation | 1 | 2004 | 11509 | 0.000 |
Why?
|